[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].

Authors:
  • WBW Birkmayer
    W Birkmayer
  • WLW Linauer
    W Linauer
  • MMM Mentasti
    M Mentasti
  • PRP Riederer
    P Riederer

  • 1 June 1974
    • journal article
    • clinical trial
    • Vol. 124  (22) , 340-4
    • PMID:4275492
Abstract
No abstract available